The first-in-Africa ex vivo drug sensitivity testing platform identifies novel drug combinations for South African leukaemia patient cohort
Abstract In South Africa, leukemia remains a major health concern, posing significant challenges in treatment due to its varied subtypes. There is an unmet need for a testing pipeline that can identify drug effects on patient samples in an ex-vivo setting. Using the pilot study with South African pa...
Saved in:
| Main Authors: | V. L. Kenmogne, M. M. Takundwa, E. E. Nweke, B. Monchusi, P. Dube, H. Maher, J. Du Toit, V. Philip-Cherian, P. N. Fru, D. B. Thimiri Govinda Raj |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-93634-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PARP inhibitor olaparib induces DNA damage and acts as a drug sensitizer in an in vitro model of canine hematopoietic cancer
by: Jayson Cagadas Pasaol, et al.
Published: (2025-07-01) -
Myeloid/natural killer cell precursor acute leukaemia. Case report and literature review
by: V. R. Gorodetsky, et al.
Published: (2022-11-01) -
Ophthalmic Manifestations In Patients of Acute Leukaemia Presenting to A Tertiary Care Centre In Western Rajasthan
by: Shilpi Kochar, et al.
Published: (2018-04-01) -
Spatial distribution of acute myeloid leukaemia in Denmark
by: Rikke Hedegaard Jensen, et al.
Published: (2025-04-01) -
Pathway activation model for personalized prediction of drug synergy
by: Quang Thinh Trac, et al.
Published: (2025-06-01)